In South Africa


In Africa



Subscribe to our Newsletters


European network of NGO's


GM Watch
GM Watch


Media Releases

Munich 26 January 2010. The Opposition Division of the European Patent Office (EPO) has today revoked a patent granted to Dr. Willmar Schwabe (Schwabe) in its entirety. The patent was opposed by the African Centre for Biosafety (ACB) from South Africa acting on behalf of a rural community in Alice, in the Eastern Cape, in collaboration with the Swiss anti-biopiracy watchdog, the Berne Declaration.

The patent was in respect of a method for producing extracts of Pelargonium sidoides and Pelargonium reniforme to make Schwabe’s blockbuster cough and colds syrup, Umckaloabo. It was revoked because the Opposition Division found that the patent did not satisfy the requirements of the European Patent Convention dealing with inventiveness.

Both species of pelargonium are harvested from the wild in the Eastern Cape and exported to Europe for the production of Umckaloabo.

Nomtunzi Api, a representative from the Alice community, expressed elation in response to the revocation, “this is the first time that a patent is challenged successfully by Africans. It gives us hope for the future because the patent ends Schwabe’s monopoly over the use of our genetic resources and traditional knowledge.”

According to Mariam Mayet of the ACB, “Patent systems are seriously flawed. It is inherently unfair that public interest NGOs should have to challenge patents, at enormous effort and expense, to bring about equity and justice in protecting resources and traditional knowledge from the South.”

For more information, view the related documents here.

Mariam Mayet +27 83 269 4309

Nomtunzi Api in Germany until 28th +49 (0) 8954 90 340 Room 301.


Content View Hits : 285856

© 2010 African Centre for Biosafety all rights reserved
The African Centre for Biosafety holds the copyright to all material on this web site, unless otherwise stated.
Material from this site may be used in other media for non-commercial use provided
the African Centre of Biosafety is acknowledged as the source of the information.
Prior written agreement is necessary for any commercial use of material or data derived from this site.